Eiji Iwama

Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer

Koichi Azuma, Keiichi Ota, Akihiko Kawahara et al. · Annals of Oncology · 2014 · 677 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer

Keiichi Ota, Koichi Azuma, Akihiko Kawahara et al. · Clinical Cancer Research · 2015 · 430 citations · Full text

Medicine, Cancer Biology, Oncology +17

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 142 citations · Full text

Medicine, Oncology, Pharmacology +14

PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements

Yasuto Yoneshima, Kayo Ijichi, Satoshi Anai et al. · Lung Cancer · 2018 · 98 citations

Medicine, Molecular Biology, Oncology +17

Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations

Eiji Iwama, Kazuko Sakai, Koichi Azuma et al. · Annals of Oncology · 2016 · 93 citations

Medicine, Molecular Genetics, Oncology +17